Boehringer Ingelheim Pharmaceuticals, Inc.

Form 483

Ridgefield, Connecticut, United StatesFEI 1219205Issued February 28, 2017

View FDA's Record for This Firm

Source: FDA inspection record. Confirmed against FDA's published inspection data for this establishment and inspection date. FDA has published the inspection and what it cited, but not the form itself, which usually takes six to twelve months. To check it, open FDA's record for this establishment on FDA's Data Dashboard, listed under FEI 1219205.

Observations1

Issue DateFebruary 28, 2017

StatusNo Warning Letter

Related Inspections10

Establishment Details

Firm: Boehringer Ingelheim Pharmaceuticals, Inc.
Location: Ridgefield, Connecticut, United States
FEI Number: 1219205
Product Type: Drugs
Issue Date: February 28, 2017
Country: United States

Inspection History, 2013 to 2025

NAI5

VAI5

NAI means No Action Indicated. VAI means Voluntary Action Indicated.

Act on This Form 483

FDA Inspection ReadinessSee how your operations would hold up to the same scrutiny.CAPA & InvestigationsScore how you would investigate and close findings like these.Talk to a SpecialistWalk through these observations with a ComplianceQuest expert.

Boehringer Ingelheim Pharmaceuticals, Inc. FDA Form 483, Ridgefield, Connecticut, February 28, 2017